Resources
Assessment of New Health Technologies 2021–22
ConsultationsThe Independent Hospital Pricing Authority’s (IHPA) core function is the pricing of public hospital services. IHPA’s Pricing Guidelines recognise that the 'Pricing of public hospital services should respond in a timely way to introduction of evidence-based, effective ne...
IHPA Work Program and Corporate Plan 2021–22
PublicationsThe Independent Hospital and Pricing Authority (IHPA) Work Program and Corporate Plan 2021–22 has been prepared in accordance with the requirements of section 225 of the National Health Reform Act 2011 and section 35(1)(b) of the Public Governance, Performance...
Draft IHPA Work Program and Corporate Plan 2021–22
ConsultationsThe Independent Hospital Pricing Authority (IHPA) invited all interested parties to provide comment on the Draft IHPA Work Program and Corporate Plan 2021–22.
Pricing Framework for Australian Public Hospital Services 2021–22
PublicationsThe Pricing Framework for Australian Public Hospital Services 2021–22 (the Pricing Framework) is the key strategic document underpinning the national efficient price (NEP) and national efficient cost (NEC) Determinations for the financial year 2021–22 (NEP21 and NEC21 r...
Assessment of new health technologies 2020–21
ConsultationsThe Independent Hospital Pricing Authority’s (IHPA) core function is the pricing of public hospital services. IHPA’s Pricing Guidelines recognise that the 'Pricing of public hospital services should respond in a timely way to introduction of evidence-based, effective ne...
IHPA Work Program 2020–21
PublicationsThe Independent Hospital Pricing Authority Work Program has been prepared in accordance with the requirements of section 225 of the National Health Reform Act 2011.
Chimeric antigen receptor T cell therapy (CAR-T cell) - guidelines for costing, counting and reconciliation of funding
PublicationsThe guidelines set out the scope, funding, costing, counting and reconciliation of funding for the chimeric antigen receptor T cell therapy (CAR-T cell) immunotherapy program using the Novartis CAR-T product Kymriah. The CAR-T program is for paediatric and young adults...
Impact of New Health Technology Framework Version 4.4
PublicationsIHPA recognises the need for the pricing of public hospital services to respond in a timely manner to the introduction of new health technologies and innovations in models of care.
IHPA Work Program 2020–21 public consultation paper
ConsultationsThe Independent Hospital Pricing Authority (IHPA) invited all interested parties to provide comment on the draft IHPA Work Program 2020–21.
Pricing Framework for Australian Public Hospital Services 2020–21
PublicationsThe Pricing Framework for Australian Public Hospital Services 2020-21 (the Pricing Framework) is the key strategic document underpinning the National Efficient Price (NEP) and National Efficient Cost (NEC) Determinations for the financial year 2020–21.
Value-based health care
PublicationsThere is a growing discussion in Australia and internationally about the need to increase focus on delivering value-based health care with a focus on patient outcomes and experience.
Assessment of new health technologies 2019–20
ConsultationsIHPA's core function is the pricing of public hospital services. IHPA’s Pricing Guidelines recognise that the "pricing of public hospital services should respond in a timely way to the introduction of evidence-based, effective new health technology and innovations in mo...